358 related articles for article (PubMed ID: 33230473)
1. YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.
Liu X; Qin J; Gao T; Li C; He B; Pan B; Xu X; Chen X; Zeng K; Xu M; Zhu C; Pan Y; Sun H; Sun L; Xu T; Wang S
Mol Ther Nucleic Acids; 2020 Dec; 22():750-765. PubMed ID: 33230473
[TBL] [Abstract][Full Text] [Related]
2. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation.
Li Q; Ni Y; Zhang L; Jiang R; Xu J; Yang H; Hu Y; Qiu J; Pu L; Tang J; Wang X
Signal Transduct Target Ther; 2021 Feb; 6(1):76. PubMed ID: 33619246
[TBL] [Abstract][Full Text] [Related]
3. N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression.
Zhang X; Su T; Wu Y; Cai Y; Wang L; Liang C; Zhou L; Wang S; Li XX; Peng S; Kuang M; Yu J; Xu L
Cancer Res; 2024 Mar; 84(6):827-840. PubMed ID: 38241695
[TBL] [Abstract][Full Text] [Related]
4. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
[No Abstract] [Full Text] [Related]
5. Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma.
Bian S; Ni W; Zhu M; Song Q; Zhang J; Ni R; Zheng W
Front Mol Biosci; 2020; 7():604766. PubMed ID: 33363211
[No Abstract] [Full Text] [Related]
6. Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism.
Su T; Huang M; Liao J; Lin S; Yu P; Yang J; Cai Y; Zhu S; Xu L; Peng Z; Peng S; Chen S; Kuang M
Hepatology; 2021 Sep; 74(3):1339-1356. PubMed ID: 33638162
[TBL] [Abstract][Full Text] [Related]
7. ELK1-mediated YTHDF1 drives prostate cancer progression by facilitating the translation of Polo-like kinase 1 in an m6A dependent manner.
Li P; Shi Y; Gao D; Xu H; Zou Y; Wang Z; Li W
Int J Biol Sci; 2022; 18(16):6145-6162. PubMed ID: 36439881
[No Abstract] [Full Text] [Related]
8. Targeting N6-methyladenosine reader YTHDF1 with siRNA boosts antitumor immunity in NASH-HCC by inhibiting EZH2-IL-6 axis.
Wang L; Zhu L; Liang C; Huang X; Liu Z; Huo J; Zhang Y; Zhang Y; Chen L; Xu H; Li X; Xu L; Kuang M; Wong CC; Yu J
J Hepatol; 2023 Nov; 79(5):1185-1200. PubMed ID: 37459919
[TBL] [Abstract][Full Text] [Related]
9. YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.
Luo X; Cao M; Gao F; He X
Exp Hematol Oncol; 2021 Jun; 10(1):35. PubMed ID: 34088349
[TBL] [Abstract][Full Text] [Related]
10. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P
Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915
[TBL] [Abstract][Full Text] [Related]
11. YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner.
Chen H; Yu Y; Yang M; Huang H; Ma S; Hu J; Xi Z; Guo H; Yao G; Yang L; Huang X; Zhang F; Tan G; Wu H; Zheng W; Li L
Cell Biosci; 2022 Feb; 12(1):19. PubMed ID: 35197112
[TBL] [Abstract][Full Text] [Related]
12. YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma.
Bai Y; Yang C; Wu R; Huang L; Song S; Li W; Yan P; Lin C; Li D; Zhang Y
Front Oncol; 2019; 9():332. PubMed ID: 31131257
[TBL] [Abstract][Full Text] [Related]
13. METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner.
Shi Y; Zhuang Y; Zhang J; Chen M; Wu S
Cancer Manag Res; 2020; 12():13173-13184. PubMed ID: 33380825
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma.
Zhao X; Chen Y; Mao Q; Jiang X; Jiang W; Chen J; Xu W; Zhong L; Sun X
Cancer Biomark; 2018; 21(4):859-868. PubMed ID: 29439311
[TBL] [Abstract][Full Text] [Related]
15. The comprehensive expression and functional analysis of m6A modification "readers" in hepatocellular carcinoma.
Qin S; Liu G; Jin H; Chen X; He J; Xiao J; Qin Y; Mao Y; Zhao L
Aging (Albany NY); 2022 Aug; 14(15):6269-6298. PubMed ID: 35963644
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis.
Peng WX; Liu F; Jiang JH; Yuan H; Zhang Z; Yang L; Mo YY
Genes Dis; 2023 Mar; 10(2):554-567. PubMed ID: 37223505
[TBL] [Abstract][Full Text] [Related]
17. Retraction Notice to: YTHDF1 Facilitates the Progression of Hepatocellular Carcinoma by Promoting FZD5 mRNA Translation in an m6A-Dependent Manner.
Liu X; Qin J; Gao T; Li C; He B; Pan B; Xu X; Chen X; Zeng K; Xu M; Zhu C; Pan Y; Sun H; Sun L; Xu T; Wang S
Mol Ther Nucleic Acids; 2022 Jun; 28():571. PubMed ID: 35592497
[TBL] [Abstract][Full Text] [Related]
18. The m6A readers
Anita R; Paramasivam A; Priyadharsini JV; Chitra S
Am J Cancer Res; 2020; 10(8):2546-2554. PubMed ID: 32905518
[TBL] [Abstract][Full Text] [Related]
19. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
20. The N6-Methyladenosine (m6A) Methylation Gene
Liu T; Yang S; Cheng YP; Kong XL; Du DD; Wang X; Bai YF; Yin LH; Pu YP; Liang GY
Cancer Manag Res; 2020; 12():11953-11964. PubMed ID: 33244271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]